GlaxoSmithKline (GSK), the pharmaceutical company behind the anti-nausea drug Zofran, has filed a request for dismissal in a lawsuit against it regarding birth injuries connected to Zofran. Many products liability cases involve a request for dismissal; often, it is the first move the defendant makes. The courts have not yet ruled on the dismissal request. … Read more…
Last week we discussed kidney problems associated with the use of the anti-nausea drug Zofran, but there are several types of birth injury your child can suffer due to the medication. A 2013 study conducted on children exposed to Zofran during the mother’s pregnancy found a two-fold increase in the risk of congenital heart defects. … Read more…
Zofran has been associated with birth defects in a series of different studies. Danish researchers found an increase in congenital heart defects in babies exposed to Zofran. A Swedish team corroborated the Danish study, and American researchers discovered that fetuses exposed to Zofran during the first trimester were 2.37 times more likely to be born … Read more…
